This inventor holds 1 USPTO granted patent. Top assignee: Pharmadesign, Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Masahiro Sokabe: Innovator in Ion Channel Inhibition
Introduction
Masahiro Sokabe is a prominent inventor based in Aichi, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides that inhibit ion channel activity. His work is crucial for advancing treatments for conditions such as atrial fibrillation.
Latest Patents
Sokabe holds a patent for "Low-molecular weight peptides inhibiting ion channel activity." This patent aims to provide innovative polypeptides that specifically inhibit the activity of mechano-sensitive channels. The invention includes mechano-sensitive channel inhibitors or remedies for atrial fibrillation that contain these polypeptides or their salts. The polypeptides have amino acid sequences represented by SEQ ID NO:1 (TVP003), SEQ ID NO:2 (TVP004), and SEQ ID NO:3 (TVP005).
Career Highlights
Masahiro Sokabe is currently associated with Pharmadesign, Inc., where he continues to push the boundaries of research in his field. His work has garnered attention for its potential applications in medical treatments.
Collaborations
Sokabe has collaborated with notable colleagues, including Takane Yokotagawa and Toshio Furuya. These partnerships have enhanced the scope and impact of his research.
Conclusion
Masahiro Sokabe's innovative work in the field of ion channel inhibition represents a significant advancement in biotechnology. His contributions are paving the way for new treatments for atrial fibrillation and other medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile